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Abstract: We tested the hypotheses that TSP-1 participates in the initiation of remodeling of small muscular arteries in 
response  to  altered blood flow  and that the N-terminal domain  of TSP-1 (hepI) can reverse  the pathological  inward 
remodeling of resistance arteries from SHR. 
We measured (1) changes in gene/protein expression in MA of 6 week old WKY and SHR exposed to either increased (+ 
100 %) or reduced blood flow (- 90 %) for 24-40 hours and (2) structural changes in MA of 12 week old SHR exposed for 
3 days to hepI in organ culture. 
In both HF and LF of WKY, mRNA expression of eNOS, sGCα1 and PKG1β were significantly reduced (p < 0.05), 
whereas mRNA of TSP1 was markedly increased (p < 0.05). In MA of young SHR, similar results were obtained except 
that eNOS mRNA was not reduced in LF. Expression of TSP1 protein was significantly increased in LF of young WKY 
and SHR (p < 0.05). Exposure of MA of 12 week old SHR to hepI (1 µmol/L) resulted in a rapid lumen diameter increase 
(+ 12 ± 2% after 3 days) without alteration in vascular reactivity, distensibility, media surface area or cell number. 
These are the first observations of reduced gene expression of eNOS/sGC/PKG and increased expression of TSP1 at the 
initiation of arterial remodeling in young WKY and SHR, irrespective of its outward or inward outcome. Furthermore, a 
fragment of TSP-1 rapidly and directly reversed pathological inward arterial remodeling of SHR in vitro. 
Keywords:  Arterial  remodeling,  eNOS,  experimental  hypertension,  gene-expression,  guanylyl  cyclase,  protein  kinase  G, 
resistance arteries, thrombospondin-1.  
INTRODUCTION 
  In small muscular arteries of young normotensive rats, an 
increase in blood flow leads to an increase in lumen diameter 
that normalizes wall shear stress. The acute response consists 
of  a  reduction  of  the  contractile  activity  of  the  vascular 
smooth  muscle  cells  [1-3].  The  response  to  a  chronic 
increase in blood flow involves  increases of  the  structural 
lumen  diameter  and  of  the  arterial  wall  mass  [4-7].  
Flow-induced  vasodilatation  and  remodeling  are  both 
endothelium-dependent  [4,  8,  9].  In  conditions  of  reduced 
blood flow, acute vasoconstriction and inward hypotrophic 
arterial  remodeling  are  observed  [6,  10].  There  is  strong 
evidence  that an  increase in  shear  stress  can stimulate the 
activity and expression of NO-synthase in the endothelium 
[9, 11-13]. The roles of NO and its main receptor soluble  
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guanylyl  cyclase (sGC)  in flow-related arterial remodeling 
are less clear.  
  We  previously  demonstrated  dedifferentiation  and 
increased  turnover  of  smooth  muscle  cells  (SMC)  during 
flow-induced  remodeling  of  small  arteries  [14].  This 
contrasts  to  the  inhibitory  effects  of  NO  on  SMC 
dedifferentiation  and  proliferation  [15,  16].  In  a  RNA 
microarray  analysis  we  observed  that  flow-related  arterial 
structural changes were preceded by altered expression of a 
large  number  of  genes  involved  in  differentiation  and 
proliferation of SMC [17]. This was in turn preceded by a 
rapid  and  transient  change  in  the  expression  of  a  small 
number of genes including that for the 82 kDa subunit of 
sGC (sGCα1, downregulated) and that for thrombospondin-1 
(TSP1,  upregulated)  [18].  The  cGMP  produced  by  sGC, 
stimulates protein kinase G (PKG), which is known to inhibit 
the expression of TSP1 in rat vascular smooth muscle cells 
[19].  A  sequence  from  the  N-terminal  heparin-binding 
domain  of  TSP1  stimulates  focal  adhesion  disassembly  
and increases cell  migration through binding to a receptor 
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suggest  that  the  eNOS/sGC/PKG  system  would  be  down- 
regulated at the transition from flow-induced vasodilatation 
to  flow-induced  remodeling,  leading  to  increased  TSP1 
expression  and  matrix  metalloproteinase  2  (MMP2) 
activation,  and  thereby  stimulation  of  a  de-adhesive  state 
facilitating reorganization of the  arterial wall material [10, 
20, 23-25].  
  Flow-induced remodeling of small arteries is impaired by 
high  blood  pressure  [26-28].  This  might  contribute  to 
reduced collateralization and arteriogenesis in ischemia and 
to the increased vascular resistance that characterizes hyper- 
tension.  There  is  convincing  evidence  in  spontaneously 
hypertensive  rats  (SHR)  and  in  human  essential  hyper- 
tension,  that the extent of inward eutrophic remodeling of 
resistance arteries is of pathogenic significance [24, 29] and 
actually  correlates  with  the  incidence  of  life  threatening 
events  [30].  Hence,  pharmacological  interventions  that 
stimulate  outward  remodeling  could  offer  a  therapeutic 
benefit. 
  The goal of this study was twofold. First, we tested the 
hypothesis  that  the  eNOS/sGC/PKG  pathway  is  down- 
regulated and that gene and protein expression of TSP1 are 
upregulated early (24-40 hours) after the induction of flow-
related  arterial  remodeling  in  vivo.  We  used  6  week  old 
WKY and 6 weeks old pre-hypertensive SHR rats to study 
differences  in  molecular  and  functional  outcomes  after 
alterations in blood flow. Secondly, we tested the hypothesis 
that a peptide mimetic of TSP1 (hepI) which induces cellular 
de-adhesion  [19-22]  can  directly  reverse  the  inward 
remodeling  of  resistance  arteries  of  12  week  old  SHR.  
For these purposes we used rat mesenteric small muscular 
arteries that were exposed to (1) altered blood flow in vivo or 
to (2) hepI during arterial organ culture at constant pressure 
and flow. 
MATERIAL AND METHODS 
Animals 
  Male  normotensive  Wistar-Kyoto  rats  (WKY)  and 
Spontaneously Hypertensive rats (SHR) were obtained from 
Charles  River  (Maastricht,  the  Netherlands).  All  animals 
were housed separately and had free access to standard food 
(SRMA-1210; Hope Farms, Woerden, the Netherlands) and 
tap  water.  All  experiments  were  conducted  according  to 
institutional  guidelines.  This  investigation  conforms  to  the 
Guide for Care and Use of Laboratory Animals as published 
by  the  US  National  Institutes  of  Health  (NIH  Publication 
No.85-23,  revised  1996),  and  all  experimental  protocols 
were  approved  by  the  Animal  Ethics  Committee  of  the 
Maastricht University. 
MA Ligation Model 
  Small mesenteric arteries (MA) of 6 week old WKY (n 
=27) and SHR (n =27) were exposed to altered blood flow in 
vivo  as  described  previously  [6,  14,  17,  31].  Briefly,  rats 
were  anesthetized  with  isoflurane  (Abbott,  Kent,  UK)  and 
after  laparotomy,  local  blood  flow  was  reduced  (LF)  by 
distal ligation of three alternate second order MA branches. 
The  MA  between  these  had  compensatory  enhanced  flow 
(HF). We previously observed in WKY that the blood flow 
averages 10% and 200% in LF and HF respectively when 
compared to second order MA outside of the surgical area 
(normal  flow,  NF)  and  that  these  interventions  ultimately 
result in inward hypotrophic (LF) and outward hypertrophic 
arterial remodeling (HF), respectively [6, 14, 31]. Animals 
received buprenorphine (0.05 mg/kg, s.c.; Schering-Plough, 
Utrecht,  Netherlands)  as  an  analgesic  at  three  time-points: 
before surgery, at the end of the day of surgery and the next 
morning. 
Gene Expression (RT-PCR) 
  At 24 hours after flow-modifying surgery, NF, HF and 
LF  MA  segments  were  isolated  and  pooled  for  each 
individual  WKY  and  SHR  rat  (n  =  9).  To  isolate  RNA, 
Trizol reagent (Invitrogen, Leek, NL) in combination with 
RNeasy Mini Kit (Qiagen, Venlo, NL) was used. RNA (100 
ng)  was  then  used  for  first-strand  cDNA  synthesis  with 
Ready-To-Go You-Prime First-Strand Beads (GE healthcare, 
Diegem,  BE)  and  pd(N)6  random  hexamer  primer  (GE 
healthcare, Diegem, BE). Plasmids containing gene fragments 
of rat MMP2, TSP1 and cyclophilin were used as standard 
curves, while a pool of cDNA of all samples was used for 
standard  curves  for  the  eNOS,  sGCα1  and  PKG1β  genes. 
Taqman  RT-PCR  for  MMP2,  TSP1  and  cyclophilin  was 
performed  in  an  ABI  Prism  7700  SDS  cycler  (Applied-
biosystems,  Bleiswijk,  NL)  in  combination  with  the 
appropriate fluorogenic probes, primer and qPCR MasterMix 
(Eurogentec, Maastricht, NL). Taqman RT-PCR for eNOS, 
sGCα1, PKG1β and cyclophilin was performed in a MyiQ 
iCycler (Biorad, Zwijndrecht, NL) with primers and qPCR 
MasterMix  containing  the  DNA  intercalating  dye,  SYBR-
green. Each PCR reaction was performed in duplicate wells 
using the following conditions, 10 min at 95˚C, followed by 
a total of 40 cycles of 15 s at 95˚C and 1 min at 60˚C (15 s at 
95˚C and 30 s at 58˚C for SYBR-green). Gene expression 
levels were normalized to the house-keeping gene cyclophilin 
in each sample.  
Contractile and Relaxing Reactivity  
  To evaluate consequences of altered gene expression for 
vasomotor control, 2 mm arterial segments were harvested at 
24 (n=4) and at 32 hours (n=8) after flow modifying surgery 
in 6 week old WKY and SHR. Preparations were mounted in 
a 5 ml organ chamber (Danish Myotechnology, Aarhus, DK) 
filled with Krebs Ringer bicarbonate solution (KRB; 37°C; 
95% O2 / 5% CO2) between an isometric force transducer 
and a displacement device. Their diameter was set at 90% of 
that  of  the  resting  vessel  at  a  transmural  pressure  of  100 
mmHg.  Effects  of  the  endothelium-dependent  vasodilator 
acetylcholine,  the  NO-donor  Na-nitroprusside  and  of  the 
non-selective  NOS-inhibitor  N
ω-L-nitro  arginine  methyl 
ester (L-NAME) were evaluated in the presence of 3 µmol/L 
indomethacin during contractions induced by an equiosmotic 
KRB  solution  containing  40  mmol/L  K
+.  These  steps  
were  taken  to  rule  out  influences  of  prostaglandins  and 
endothelium-derived  hyperpolarizing  factors.  Because 
depolarizing high K
+ buffer can stimulate release of neuro- 
transmitters  from  peri-arterial  nerves,  experiments  were 
initiated after exposure of the arteries to phenoxybenzamine 
(1  µmol/L,  10  min)  and  capsaicin  (1  µmol/L,  20  min)  
which  irreversibly  block  α-adrenoceptors  and  peri-arterial 
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Protein Expression  
  Protein levels were investigated in view of discrepancies 
between  mRNA  levels  on  the  one  hand  and  vasomotor 
responses on the other hand. At 32 hours and at 40 hours 
after flow-modifying surgery, NF, HF and LF MA segments 
(n=9, each group) were isolated  and pooled from 3 WKY 
and 3 SHR rats and snap-frozen in liquid nitrogen. Pooled 
arteries were crunched at -80
0C and resuspended in ice cold 
RIPA buffer (50 mM HCl pH 7.4, 150 mM NaCl, 1% NP-
40, 0.25% Na-deoxycholate  and 1 mM EDTA) containing 
protease  and  phosphatase-inhibitors  (1mM  PMSF,  1  mM 
NaVO4, 1 mM NaF, 1 µg/ml aprotinin, 1 µg/ml pepstatin and 
1 µg/ml leupeptin) to extract total protein. The lysates were 
cleared by centrifugation. Protein content of the lysates was 
determined  with  the  BCA  method  [33].  Lysates  were 
subsequently  run  on  a  criterion  bis/tris  gradient  gel,  and 
blotted  to  a  nitrocellulose  membrane.  Membranes  were 
blocked  with  1:1  oddysey  blocking  buffer:PBS  and  were 
subsequently  incubated  with  antibodies  diluted  in  1:1 
oddysey  blocking  buffer:PBS  against:  eNOS  (BD  Trans- 
duction Laboratories, Franklin Lakes, USA, 1:2500), sGCα1 
(Santa Cruz, Santa Cruz, USA 1:2000), PKG1β (Biovision, 
Zurich, CH, 1:500), MMP2 (Santa Cruz, Santa Cruz, USA 
1:500,detecting  the  pro  (72kDa)-  and  the  active  (62kDa) 
form  of  MMP2)  and  TSP-1  (Abcam,  Cambridge,  USA, 
1:500).  Primary  antibodies  were  detected  with  secondary 
antibodies labeled with the near infrared dye IRdye800 and 
visualized with an odyssey detection system. TSP-1 antibody 
was detected with secondary antibodies labeled with biotin. 
Biotin  was  subsequently  detected  with  IRdye800  labeled 
streptavidin.  Protein  expression  levels  were  normalized  to 
the house-keeping protein GAPDH in each run. 
Arterial Organ Culture  
  To investigate whether hepI could reverse inward arterial 
remodeling  in  hypertension,  we  used  MA  segments  of  
12 week old SHR in organ culture as described by Bakker  
et  al.  [10,  34].  The  vessels  were  mounted  on  two  glass 
micropipettes  in  a  stainless  steel  organ  chamber.  Vessels 
were pressurized  at 80 mmHg (no flow) and  incubated  in 
Hanks balanced salt solution (HBSS) for 60 min  at 37°C, 
before  baseline  measurements  of  diameter  and  reactivity 
were  obtained.  Thereafter  the  vessels  were  exposed  intra-
luminally  as  well  as  extra-luminally  to  culture  medium 
(Leibovitz (n=6) or 5% dFCS-DMEM (n=6)) with or without 
1  µmol/L  hepI  for  3  days.  The  parallel  experiments  with 
Leibovitz  and  5%  dFCS  in  DMEM  yielded  quantitatively 
identical  results.  The  data  were  pooled  for  subsequent 
analysis. 
  At  the  start  of  the  experiments  and  at  daily  intervals, 
passive  pressure-diameter  (P/D)  curves  were  constructed 
[13]. The culture medium was replaced by Ca
2+-free HBSS 
containing 10 µmol/L Na-nitroprusside to inactivate arterial 
smooth muscle tone. The cannulated arterial segments were 
pressurized  using  a  feedback  controlled  pressure  source 
(Living  Systems  Instrumentation,  Burlington,  USA)  and 
placed  on  the  stage  of  an  invertoscope  (Nikon  TMS, 
Abingdon, USA) equipped with a video camera (Stemmer) 
and a digital device (LSI) for recording of lumen diameter. 
Intra-arterial pressure was increased in 10 mmHg steps from 
20 to 120 mmHg. After each step, the vessel was allowed to 
equilibrate until a stable diameter was reached (2 minutes). 
Findings were expressed as percentage change from vessel 
diameter on day 0 at 80 mmHg. From the P/D relationships 
arterial  distensibility  was  calculated  by  the  following 
formula: DC = (1/ΔP)*(ΔD/Dn-1)*100 (DC = distensibility, P 
= intraluminal pressure, D = diameter at a given intraluminal 
pressure). After the highest pressure was reached, pressure 
was  returned  to  80  mmHg  and  the  HBSS-solution  was 
replaced  by  culture  medium  with  or  without  1.0  µmol/L 
hepI. 
  On day 0 and day 3 of the culture period the viability  
of the vessels was verified by recording diameter changes  
at 80 mmHg in response to 1 µmol/L serotonin, 10 µmol/L 
phenylephrine and 1 µmol/L acetylcholine in HBSS. Finally 
the  vessels  were  fixed  in  neutral  buffered  formalin  at  80 
mmHg and 37°C and stored in 70% ethanol. 
Histology and Morphometry 
  Fixed  vessels  were  embedded  in  paraffin  and  cross-
sections (4 µm) were stained with Lawson’s solution (Boom, 
Meppel,  the  Netherlands)  to  visualize  the  internal  and 
external  elastic  laminae.  Cross-sectional  area  (mCSA), 
thickness, cellular density of the tunica media, and the lumen 
diameter were determined as previously described [6, 13, 14, 
17, 26, 31]. 
Solutions, Culture Media and Drugs 
  Leibovitz  medium  (Invitrogen,  Leek,  NL)  was  supple- 
mented with 1 mg/mL albumine (Sigma Aldrich, Zwijndrecht, 
NL), 20 mg/mL ciprofloxacin (Bayer, Leverkusen, DE), 100 
U/mL  penicillin,  100  µg/mL  streptomycin  and  2.5  U/mL 
amphotericin B (Invitrogen, Leek, NL). DMEM (Invitrogen, 
Leek, NL) was supplemented with 2.5 mM glutamine, 100 
IU/mL penicillin, 100 µg/mL streptomycin and 5% dialyzed 
fetal-calf serum. All pharmacological agents were purchased 
from  Sigma  Aldrich,  (Zwijndrecht,  NL).  The  hepI  peptide 
(ELTGAARKGSGRRLVKGPD)  was  synthesized  by 
Anaspec Inc (San Jose, USA) and purified by HPLC [21]. 
The peptide was confirmed to be >95% pure by HPLC and 
mass spectrometry. 
Statistical Analysis 
  Results  are  expressed  as  means  ±  SEM.  Statistical 
significance of differences between groups was evaluated by 
analysis of variance (ANOVA for consecutive measurements 
for pressure-diameter curves) or 1-way ANOVA followed by 
Bonferroni or paired t-test (SPSS 11.5). A value of P<0.05 
was considered significant.  
RESULTS 
Gene Expression Under Basal Conditions 
  Fig. (1) illustrates expression of genes encoding protein 
kinase G (PKG) and candidate modulators and targets of this 
enzyme in mesenteric small arteries of 6 week old WKY and 
SHR rats. In control arteries with normal flow (NF), mRNA 
levels were high for  sGCα1  and PKG1β, intermediate for 
eNOS, and low for MMP2 and TSP1. Although expression 
of eNOS tended to be smaller in NF of SHR, the expression 
levels of all five genes did not differ significantly between 
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Altered  Gene  Expression  During  Initiation  of  Flow-
Related Arterial Remodeling In Vivo 
  Changes in gene expression in MA exposed for 24 hours 
to  altered  blood  flow  in  vivo  are  summarized  in  Fig.  (1). 
Consistent  with  earlier  RNA  microarray  observations  [17, 
18], the expression of sGCα1 was significantly reduced and 
that of TSP1 was markedly increased in arteries from WKY 
rats  exposed  to  high  blood  flow  (HF).  Surprisingly,  the 
findings were very similar in vessels exposed to increased 
(HF) or reduced (LF) blood flow. In both HF and LF arteries 
of WKY rats, the expression of eNOS, sGCα1 and PKG1β 
was  significantly  reduced,  whereas  TSP1  was  markedly 
increased and MMP2 was not appreciably altered. In HF of 
SHR, qualitatively and quantitatively similar findings were 
obtained, except that there was a less marked downregulation 
of eNOS possibly due to the already reduced basal levels. 
Also in arteries of SHR exposed to reduced blood flow (LF), 
largely similar results were obtained, with the exception that 
eNOS and TSP1 expression were affected to a lesser extent. 
Collectively these results indicate that either an increase or a 
decrease in blood flow both lead to a concurrent reduction of 
eNOS,  sGCα1  and  PKG1β  and  to  a  marked  increase  of 
TSP1 mRNA levels within 24 hours in rat mesenteric small 
muscular arteries.  
Fig. (1). mRNA expressions of eNOS, sGCα1, PKG1β, TSP1 and MMP2 in mesenteric small arteries exposed to normal blood flow (NF, 
black bars) or for 24 hours to increased blood flow (HF, hatched bars) or reduced blood flow (LF, crosshatched bars) in 6 week old Wistar 
Kyoto (WKY) rats and Spontaneously Hypertensive rats (SHR)  in vivo, normalized to the housekeeping gene  cyclophylin. Results  are 
expressed as the mean ± SEM (n = 6). * p<0.05 versus NF. 54    The Open Cardiovascular Medicine Journal, 2012, Volume 6  Lemkens et al. 
Vasomotor Responses 
  To  evaluate  potential  functional  consequences  of  the 
observed downregulation of the NO/sGC/PKG pathway, we 
recorded arterial contractile reactivity in vitro  in MA of  6 
week  old  WKY  and  SHR  rats.  At  24  hours  after  flow-
modifying  surgery  there  were  no  statistically  significant 
differences between NF, HF or LF arteries (n = 4-6, data not 
shown). Because changes in the abundance and activity of 
proteins lag behind changes in mRNA expression, functional 
analyses were repeated at 32 hours after altered blood flow 
in  vivo.  These  results  are  summarized  in  Fig.  (2).  The 
diameter  of  WKY  LF  arteries  was  significantly  reduced 
which is consistent with the rapid inward remodeling of LF 
in vivo [14]. L-NAME significantly increased the contractile 
response to 40 mmol/L K
+ in NF arteries of WKY and SHR. 
Relaxing responses of depolarized vessels  to acetylcholine 
(in the presence of indomethacin) and to Na-nitroprusside (in 
Fig. (2). In vitro contractile reactivity of mesenteric small arteries of 6 week old WKY rats (panel A) and SHR rats (panel B) exposed to 
normal flow (black bars) or for 32 hours to increased (hatched bars) or reduced blood flow (cross-hatched bars). Means ± SEM (n = 8-11). 
Normalized diameter and maximal contraction in response to 125 mmol/L K
+ (top left) and the effect of indomethacin and L-NAME on 
contractile  responses  to  40  mmol/L  K
+  (top  right)  are  shown  along  with  the  relaxing  responses  to  acetylcholine  during  K
+-induced 
contraction in the presence of indomethacin (bottom left) and the relaxing responses to Na-nitroprusside during K
+-induced contraction in the 
presence of indomethacin and L-NAME (bottom right) for NF (closed circle), HF (open circle) and LF (closed triangle). *p<0.05 versus NF; 
#p<0.05 INDO versus INDO + L-NAME. TSP1 in Arterial Remodeling  The Open Cardiovascular Medicine Journal, 2012, Volume 6    55 
the presence of indomethacin and L-NAME) did not differ 
between  NF,  HF  or  LF  arteries  (Fig.  2A).  These  findings 
indicate  that  the  marked  and  concurrent  reductions  of  the 
mRNA  levels  for  eNOS,  sGCα1  and  PKG1β  were  not 
accompanied  by  reduced  relaxing  responses  to  basal  and 
stimulated  endothelium-derived  or  exogenous  NO  during 
initiation  of  outward  (HF)  or  inward  (LF)  flow-related 
arterial remodeling in WKY. Similar results were obtained in 
SHR,  as  shown  in  Fig.  (2B).  In  contrast  to  WKY,  the 
diameter of SHR LF arteries did not differ from that of NF 
and HF arteries. 
Altered  Protein  Expression  During  Initiation  of  Flow-
Related Arterial Remodeling In Vivo 
  Fig. (3) summarizes changes in protein expression in MA 
exposed  for  32  (left  panel)  and  40  hours  (right  panel)  to 
altered blood flow in vivo. These time-points were chosen to 
allow protein synthesis to occur and are based on the 24 hour 
gene expression experiments and the earlier observation that 
in low flow conditions specifically, the inward remodeling 
response manifests within 2 days [14]. In both HF and LF 
arteries of WKY and SHR rats, the protein levels of eNOS, 
sGCα1, PKG1β and MMP2 (pro/act) were not significantly 
altered  after  32  and  40  hours  of  flow  modifying  surgery  
(Fig. 3 A-E). Protein expression for TSP1 was significantly 
increased in LF arteries of both WKY and SHR (Fig. 3F). 
After  40  hours  of  exposure  to  LF,  protein  expression  of 
TSP1 was below threshold in NF, HF and LF arteries.  
Arterial  Structural  Effects  of  the  hepI  Sequence  of  
TSP1 
  To evaluate structural consequences of upregulated TSP1 
mRNA  and  protein  expression,  isolated  arteries  were 
exposed to hepI under  constant conditions of pressure (80 
mmHg) and flow (no flow) in vitro. These experiments were 
deliberately performed in arteries of 12 week old SHR that 
display an inward eutrophic remodeling which contributes to 
the increased peripheral resistance and blood pressure [24, 
29]. In the untreated arteries, the diameter at 80 mmHg and 
the  relationship  between  passive  diameter  and  transmural 
pressure  did  not  change  during  the  3  day  culture  period  
(Fig. 4). The presence of 1 µmol/L hepI, however, resulted  
in  an  increase  of  the  diameter  at  80  mmHg  and  in  an  
upward shift of the pressure-diameter curves (p < 0.05 for 
day 1, day 2 and day 3)(Fig. 4). Arterial structural diameter 
was increased by 7.5 ± 1.9 % within 24 hours and increased 
further  to  +12.6  ±  2.4  %  after  3  days  (Fig.  4).  Exposure  
to  hepI  did  not  modify  calculated  distensibility  (Fig.  4), 
general  arterial  histology  (not  shown),  and  did  not  result  
in statistically significant  changes in media cross sectional 
area (13693 ± 4043 µm
2 versus 12881 ± 3182 µm
2) or cell 
number  (52  ±  11  versus  54  ±  8  nuclear  profiles/section) 
indicating  that  the  hepI-induced  outward  remodeling  was 
eutrophic in nature.  
  In  an  additional  set  of  experiments  we  tested  whether 
hepI displayed vasomotor  effects.  Contractile responses of 
freshly isolated arteries to 25 mmol/L K
+ were reduced by 
 
 
Fig. (3). Changes in protein expression of eNOS (A), sGCα1 (B), PKG1β (C), MMP2 (pro/act, D/E) and TSP1 (F), in mesenteric small 
arteries exposed for 32 and 40 hours to normal (black bars), increased (hatched bars) or reduced (crosshatched bars) blood flow in 6 week old 
WKY and SHR rats in vivo. Means ± SEM (n = 6). *p<0.05 versus NF. 56    The Open Cardiovascular Medicine Journal, 2012, Volume 6  Lemkens et al. 
acetylcholine and enhanced by indomethacin and L-NAME 
indicating  intact  endothelium.  Depolarization-induced 
contractions were not modified by 0.0001 - 1.0 µmol/L hepI 
indicating that hepI does not display major acute vasomotor 
effects.  After  3  days  in  vitro,  1  µmol/L  serotonin  and  10 
µmol/L phenylephrine reduced arterial diameter to 45 ± 4% 
and 47 ± 3% of baseline, respectively, in untreated vessels 
and to 44 ± 3% and 46 ± 4% of baseline, respectively, in 
arteries that had been exposed to hepI. Moreover, 1 µmol/L 
acetylcholine reversed the serotonin-induced constriction by 
66 ± 5% in untreated vessels and by 63 ± 5% in hepI treated 
arteries.  These  findings  indicate  that  exposure  to  hepI  for 
three  days  did  not  adversely  affect  vasoconstriction  or 
endothelium-dependent vasodilatation. 
DISCUSSION 
  We demonstrate for the first time i) rapid and concurrent 
downregulation  of  eNOS,  sGC  and  PKG  mRNA  and 
upregulation of TSP1 mRNA expressions at the initiation of 
flow-related  remodeling  and  ii)  a  direct  effect  of  the 
calreticulin/LRP1  binding  sequence  of  TSP1  on  the 
structural lumen diameter in small muscular arteries of the 
rat. That the latter was observed in the narrowed arteries of 
SHR rats, suggests a therapeutic potential for the pathways 
involved. 
  In  arteries,  wall  shear  stress  and  circumferential  wall 
stress  are  homeostatically  controlled  by  vasomotor  and 
structural changes of lumen diameter and wall thickness [6, 
9, 35]. The transition from the acute vasomotor responses to 
the chronic structural responses is poorly understood. Here 
we concentrated on subacute effects of altered local blood 
flow  in  the  interconnected  arterial  trees  of  the  mesenteric 
vascular  bed.  In  this  system  of  young  rats,  increased  and 
reduced blood flow ultimately lead to outward hypertrophic 
and  inward  hypotrophic  remodeling,  respectively  [5-7,  14, 
17, 18, 27, 28, 31]. Both structural responses involve marked 
changes  in  gene  expression  and  in  cellular  turnover  and 
differentiation [14, 17] which are preceded by a rapid and 
transient  transcriptional  response  of  a  comparatively  small 
number  of  genes  [18].  The  latter  candidate  initiators  of 
remodeling  might  be  a  target  for  interventions  aimed  at 
improved  collateralization  in  ischemia  and  reversal  of  the 
adverse  structural  narrowing  of  resistance  arteries  in 
hypertension. We focussed on changes occurring within 24 
hours  in  a  cell-cell  signaling  and  signal  transduction  
system  that  was  shown  to  be  involved  in  flow-induced 
vasodilatation  [9,  11-13],  vascular  smooth  muscle  cell  de-
differentiation  and  proliferation  [15,  16]  and  in  the 
expression  of  a  modulator  of  cellular  adhesion  and  extra- 
cellular matrix, such as TSP1 [19, 22]. 
  The  wall  shear  stress  resulting  from  blood  flow  can  
alter  the  activity  and  expression  of  type  III  NOS  (eNOS)  
in  the  endothelium  [9,  11,  12].  The  main  NO-receptor  in 
vascular  smooth  muscle  is  the  heterodimeric  soluble 
guanylyl cyclase sGCα1β1 [36-38]. The cGMP produced by 
this enzyme stimulates protein kinases, in the vascular wall 
Fig. (4). Effects of time (control, top left) and 1 µmol/L hepI (hepI, top right) on passive pressure-diameter relationships in mesenteric small 
arteries (MA) of 12 week old SHR during organ culture. Calculated distensibility for control MA (day 0 and day 3, bottom left) and hepI 
treated MA (day 0 and day 3, bottom right). Values are shown as means ± SEM (n = 12). Closed circle, day 0; open circle, day 1; closed 
triangle, day 2; open triangle, day 3. *p<0.05, versus day 0. TSP1 in Arterial Remodeling  The Open Cardiovascular Medicine Journal, 2012, Volume 6    57 
primarily  PKG1β  [36-38],  which  inhibit  vasoconstriction, 
dedifferentiation and expression of TSP1 in vascular smooth 
muscle [19, 22]. In this study we confirmed several earlier 
findings like (i) inhibitory effects of low blood flow on the 
mRNA  expression  of  eNOS  [9,  12]  and  (ii)  association 
between reduced mRNA expression of PKG and increased 
mRNA expression of TSP1 [19, 22]. The overall picture of 
our observations is, however, unexpected. Reduced mRNA 
expression  of  eNOS  was  accompanied  by  reduced  mRNA 
expression of sGCα1 and PKG1β, which is not observed in 
eNOS-deficient mice [36, 37, 39, 40]. The mRNA expression 
of both sGCα1 and of PKG1β was reduced, although in a 
variety of vascular SMC culture models a negative feedback 
interaction  between  these  effectors  has  been  demonstrated 
[41]. Most surprising is that concurrent down regulation of 
eNOS, sGCα1 and PKG1β gene expressions were observed 
in  vessels  exposed  to  reduced  blood  flow  and  in  vessels 
exposed  to  increased  blood  flow.  This  was  found  in  
two strains of rats (WKY and SHR). The finding suggests  
a  general  response  to  an  altered  hemodynamic  micro- 
environment that prepares the tissue for adequate structural 
changes  aimed  at  restoring  stresses  independent  from  the 
direction of the initiating change. This may be required to 
initiate cellular de-differentiation, de-adhesion and turnover 
and extracellular matrix reorganization that take part in both 
outward hypertrophic remodeling and in inward hypotrophic 
remodeling. 
  In addition, we studied protein expression and vasomotor 
responses  to  monitor  turnover  and  activity  of  eNOS/sGC/ 
PKG  pathway  components  in  response  to  altered  blood  
flow in vivo. Protein expression of TSP-1 was increased in 
LF  MA  of  both  WKY  and  SHR  at  32  hours  after  flow 
modifying  surgery.  However,  no  statistically  significant 
changes  in  the  protein  levels  of  the  other  proteins  and  
in  vasomotor  responses  to  NO-synthase  blockade,  an 
endothelium dependent vasodilator and an NO-donor were 
observed  after  32  or  40  hours  exposure  of  rat  arteries  to 
altered blood flow. 
  Although  shear  stress  can  at  least  transiently  stimulate 
activity  and  expression  of  eNOS  [9,  11,  12],  there  is  no 
consensus  on  the  precise  role  of  eNOS  in  flow-induced 
arterial remodeling. Caveolin-mediated activation of eNOS 
seems to be required for the inward remodeling of ligated 
carotid arteries in mice [42]. In a rabbit carotid artery A-V 
fistula model, chronic L-NAME treatment inhibits outward 
remodeling  and  the  contribution  of  NO  can  be  attributed  
to  stimulation  of  MMP9  [43].  Chronic  L-NAME  does, 
however,  not  impair  inward  and  outward  remodeling  of 
mesenteric small arteries in the rat model that we used here 
[31]. In this rat mesenteric model, doubling of blood flow 
does not result in increased expression of eNOS after 2 or 7 
days, whereas a four fold increase in blood flow leads to a 
significant increase in eNOS at these time points [44]. In a 
similar mouse mesenteric model, Dumont et al. [7] observed 
increased  expression of eNOS  and activity of  MMP9 at  4 
days that contributed to the structural outcome. Differences 
between species, arteries and extent of blood flow alterations 
may contribute to these divergent findings. TSP1, as already 
mentioned,  is  a  large  matricellular  protein  with  many 
functions,  particularly  the  ability  of  the  hepI  sequence  of 
TSP1 to signal cellular de-adhesion [22]. This sequence of 
TSP1 binds to the receptor co-complex of calreticulin/LRP1 
and  stimulates  focal  adhesion  disassembly  and  increased  
cell  migration  [20,  22,  45,  46].  To  evaluate  a  possible 
contribution  of  TSP1  to  small  artery  remodeling  arteries 
were exposed to the hepI peptide mimetic in vitro [19]. 
  As  described  by  Bakker  et  al  [34,  47],  rat  mesenteric 
small  arteries could be  maintained for 72 hours in arterial 
organ culture at constant pressure and in the absence of flow 
without  noticeable  alterations  in  viability  of  the  smooth 
muscle  and  endothelium.  In  this  static  in  vitro  setting  the 
arterial  diameter  did  not  change  while  narrowing  of  LF 
arteries developed within 40 hours in vivo (present study and 
[14]). This indicates that the absence of flow is in itself not a 
potent  stimulus  for  inward  remodeling.  Administration  of 
hepI in vitro resulted in a diameter increase and in an upward 
shift of the pressure-diameter relationship within 24 hours. 
The 12% increase in lumen diameter observed with hepI in 
vitro is comparable to the diameter response to doubling of 
blood  flow  in  vivo  [14,  17,  31].  HepI-induced  outward 
remodeling was not accompanied by changes in wall mass or 
vasomotor  control.  Although  TSP1  was  upregulated  in 
vessels exposed to increased or reduced blood flow in vivo, 
exogenous  hepI  caused  outward,  but  not  inward  arterial 
remodeling.  The  role  of  vasomotor  responses  in  arterial 
remodeling  may  help  explain  this  paradox.  Prolonged 
vasoconstriction  has  been  shown  to  reorganize  cell-matrix 
interactions  [23]  and  to  lead  to  a  narrower  arterial  lumen 
(inward remodeling) in vitro [10, 48]. We now propose that 
TSP1 expressed in response to a change in shear stress can 
lead to an intermediate de-adhesive state [20] and that the 
levels of transmural pressure and vasoconstrictor/vasodilator 
tone  will  determine  the  outward  or  inward  nature  of  the 
resulting  arterial  structural  change.  A  distending  pressure, 
but no vasomotor tone was present during culture allowing 
the  hepI  induced  de-adhesive  state  to  result  in  outward 
arterial  remodeling.  That  3  days  of  exposure  to  hepI 
increased  diameter  without  altering  arterial  distensibility 
contributes  to  the  suggestion  that  the  remodeling  resulted 
from a de-adhesive state rather than from major changes in 
the extracellular matrices. 
  Effects  of  altered  blood  flow  on  the  mRNA’s  and 
proteins  investigated  were  largely  similar  in  6  week  old 
WKY and SHR. This suggests that the pathways investigated 
are  not  likely  involved  in  the  inward  remodeling  of 
resistance  arteries  that  contributes  to  the  elevated  total 
peripheral  vascular  resistance  and  blood  pressure  in  SHR 
[24, 29, 30]. Despite this limited pathophysiological relevance, 
hepI,  that  lacks  apparent  vasomotor  effects  was  found  to 
rapidly  and  directly  reverse  inward  arterial  remodeling  
of  mesenteric  resistance  arteries  of  the  hypertensive  12  
week  old  SHR.  This  strengthens  the  proposal  that  small 
artery structure is a directly amenable pharmaco-therapeutic 
target. 
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ABBREVIATIONS 
ANOVA  =  Analysis of variance 
BCA  =  Bicinchoninic acid assay 
cGMP  =  Cyclic guanosine monophosphate 
CSA  =  Cross-sectional area 
dFCS  =  Dialyzed fetal calf serum 
DMEM  =  Dulbecco's Modified Eagle Medium 
eNOS  =  Endothelial nitric oxide synthase 
GAPDH  =  Glyceraldehyde  3-phosphate  dehydro- 
genase 
HBSS  =  Hanks balanced salt solution 
HF  =  High Flow 
HPLC  =  High Pressure Liquid Chromatgraphy 
KRB  =  Krebs Ringer bicarbonate solution 
LF  =  Low Flow 
L-NAME  =  N
ω-L-nitro arginine methyl ester 
LRP1  =  Low  density  lipoprotein  receptor-related 
protein 1 
MA  =  Mesenteric resistance arteries 
MMP2  =  Matrix metalloproteinase 2 
MMP9  =  Matrix metalloproteinase 9 
mRNA  =  Mesenger Ribonucleic acid 
NF  =  Normal Flow 
NO  =  Nitric Oxide 
PBS  =  Phosphate buffered saline 
PKG1β  =  Protein kinase G1b 
RIPA  =  Radio-Immunoprecipitation Assay 
SEM  =  Standard error of mean 
sGCα1  =  Alpha1 subunit of soluble guanylyl cyclase 
SHR  =  Spontaneousy hypertensive rat 
SMC  =  Smooth muscle cells 
TSP-1  =  Thrombospondin-1 
WKY  =  Wistar Kyoto 
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